Prevention, screening, and treatment for heavy drinking and alcohol use disorder

J Knox, DS Hasin, FRR Larson, HR Kranzler - The Lancet Psychiatry, 2019 - thelancet.com
Heavy drinking and alcohol use disorder are major public health problems. Practitioners not
specialising in alcohol treatment are often unaware of the guidelines for preventing …

Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis

J Gratacós-Ginès, P Bruguera, M Pérez-Guasch… - Hepatology, 2024 - journals.lww.com
Medications for alcohol use disorder promote abstinence in a... : Hepatology Medications for
alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a …

The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder

VI Reus, LJ Fochtmann, O Bukstein… - American Journal of …, 2018 - Am Psychiatric Assoc
The goal of this guideline1 is to improve the quality of care and treatment outcomes for
patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric …

Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial

RF Anton, P Latham, K Voronin, S Book… - JAMA internal …, 2020 - jamanetwork.com
Importance Although an estimated 30 million people meet criteria for alcohol use disorder
(AUD), few receive appropriate pharmacotherapy. A more personalized, symptom-specific …

A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients—the ALPADIR study

M Reynaud, HJ Aubin, F Trinquet, B Zakine… - Alcohol and …, 2017 - academic.oup.com
Aims Alcohol dependence is a major public health issue with a need for new
pharmacological treatments. The ALPADIR study assessed the efficacy and safety of …

Medications for alcohol use disorders: An overview

M Akbar, M Egli, YE Cho, BJ Song… - Pharmacology & …, 2018 - Elsevier
Patients who suffer from alcohol use disorders (AUDs) usually go through various socio-
behavioral and pathophysiological changes that take place in the brain and other organs …

Cannabidiol as a novel candidate alcohol use disorder pharmacotherapy: a systematic review

J Turna, SK Syan, BN Frey, B Rush… - Alcoholism: Clinical …, 2019 - Wiley Online Library
There is substantial interest in the therapeutic potential of cannabidiol (CBD), a
nonpsychoactive cannabinoid found in plants of the genus Cannabis. The goal of the current …

Pharmacotherapy of alcoholism–an update on approved and off-label medications

M Soyka, CA Müller - Expert Opinion on Pharmacotherapy, 2017 - Taylor & Francis
Introduction: Only a few medications are available for the treatment of alcohol use disorders
(AUDs). Areas covered: This paper discusses approved AUD medications, including the …

Gender differences in use of alcohol treatment services and reasons for nonuse in a national sample

PA Gilbert, G Pro, SE Zemore, N Mulia… - Alcoholism: Clinical …, 2019 - Wiley Online Library
Background The majority of adults with alcohol use disorders do not obtain help, and
women are less likely to utilize alcohol services than men. We sought to quantify gender …

Differences between treatment‐seeking and nontreatment‐seeking alcohol‐dependent research participants: an exploratory analysis

MCH Rohn, MR Lee, SB Kleuter… - Alcoholism: Clinical …, 2017 - Wiley Online Library
Background Alcoholism is a chronic relapsing disorder with complex behavioral and
functional heterogeneity. To date, attempts to characterize subgroups of alcohol‐dependent …